CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $96,431
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$96,431. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-01-21 | RICHMAN ERIC I Director | Shares withheld for taxes | −3,057 | $3.42 | $10K | 109,822 |
| 2011-01-21 | Cook Francesca M VP, Policy & GVMNT Affairs | Shares withheld for taxes | −2,574 | $3.42 | $9K | 40,690 |
| 2011-01-21 | Riddle Valerie D VP, Medical Director | Shares withheld for taxes | −2,750 | $3.42 | $9K | 53,323 |
| 2010-12-23 | RICHMAN ERIC I Director | Grant or award | +35,000 | 112,879 | ||
| 2010-12-23 | RICHMAN ERIC I Director | Grant or award · Stock Options (right to buy) | +225,000 | 225,000 | ||
| 2010-12-13 | Riddle Valerie D SVP, Medical Director | Grant or award · Stock Options (right to buy) | +37,500 | 37,500 | ||
| 2010-12-08 | FUERST THOMAS RICHARD Chief Scientific Officer | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2010-12-08 | Cook Francesca M SVP, Policy & Gov't Affairs | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2010-12-08 | Karp Jordan P SVP, General Counsel | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2010-12-08 | Reinhart Charles A. III SVP, Chief Financial Officer | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2010-11-24 | SCHAFFER DERACE L Director | Conversion | +444,044 | $2.54 | $1.1M | 1,285,208 |
| 2010-11-24 | SCHAFFER DERACE L Director | Conversion · 10% Convertible Note | −0 | 0 | ||
| 2010-11-22 | PAPPAJOHN JOHN Director | Conversion | +444,044 | $2.54 | $1.1M | 444,044 |
| 2010-11-22 | PAPPAJOHN JOHN Director | Conversion · 10% Convertible Note | −0 | 0 | ||
| 2010-11-03 | MPM BIOVENTURES III LLC 10% owner | Conversion | +2,428,171 | $2.54 | $6.2M | 5,917,614 |
| 2010-11-03 | MPM BIOVENTURES III LLC 10% owner | Purchase | +430,000 | $3.50 | $1.5M | 6,347,614 |
| 2010-11-03 | MPM BIOVENTURES III LLC 10% owner | Conversion · 10% Convertible Note | −0 | 0 | ||
| 2010-11-03 | EVNIN LUKE 10% owner | Conversion | +2,428,171 | $2.54 | $6.2M | 5,917,614 |
| 2010-11-03 | EVNIN LUKE 10% owner | Purchase | +430,000 | $3.50 | $1.5M | 6,347,614 |
| 2010-11-03 | EVNIN LUKE 10% owner | Conversion · 10% Convertible Note | −0 | 0 |
Page 46 of 50 · 1,000 trades